Neurodegenerative disease mechanism and potential drug identified

June 6, 2017 by Pat Bailey

Two new studies of progressive, neurodegenerative diseases linked to defects in cells' mitochondria offer hope for developing a new biomarker for research and diagnostics, and a drug for treating such diseases, report researchers at the University of California, Davis.

Both studies, co-authored by biochemist Gino Cortopassi in the UC Davis School of Veterinary Medicine, have implications for Friedreich's ataxia, a rare, inherited that affects 6,000 people in the United States.

Friedreich's is characterized by progressive neurodegeneration in the spine, as well as muscle weakness, heart disease and diabetes.

Findings from the two studies are being published this week in the journal Human Molecular Genetics.

Mitochondrial diseases

Friedrich's ataxia is one of several serious diseases caused by dysfunctional mitochondria—microscopic structures inside the cell that generate the cell's chemical energy, and play a key role in cell growth, function and death.

In addition to Friedreich's ataxia, other include Leber's optic neuropathy, myoneurogenic gastrointestinal encephalopathy, and myoclonic epilepsy with ragged red fibers—complex names for unusual but devastating disorders.

There are currently no Food and Drug Administration-approved therapies for treating mitochondrial diseases, including Friedreich's ataxia.

Protein defect decreases mitochondria numbers

Inherited deficiencies in the mitochondrial protein frataxin cause Friedreich's ataxia, but it has been unclear how the deficiency in this single protein leads to the death of neurons and degeneration of muscles.

One of the new studies shows that a loss of the frataxin protein causes a decrease in mitochondrial number in blood and skin cells from patients with Friedreich's ataxia. Mice with a deficiency in the protein also have fewer mitochondria.

There are two main applications of the new knowledge, Professor Cortopassi said.

"Knowing now that the frataxin deficiency causes a shortage of mitochondria, we and others may be able to use the number of mitochondria as a biomarker for determining the disease severity and progression in Friedreich's ataxia patients," he said. "Such a biomarker could also be used to evaluate the effectiveness of new drugs for treating the disease."

MS drug shown to increase mitochondria production

In the second study, Cortopassi and colleagues focused on the drug dimethyl fumarate, or DMF, already approved by the FDA for treating adult patients with a relapsing form of multiple sclerosis as well as psoriasis, an autoimmune skin disease.

DMF is known to help prevent inflammation and protect cells from damage.

In this study, the researchers examined the effects of DMF on human fibroblast (skin) cells, mice and human patients with multiple sclerosis.

The researchers demonstrated that DMF dosing causes increased mitochondrial numbers in human skin fibroblasts, in mouse tissues and in humans. The researchers also showed that the enhanced mitochondrial gene expression.

"Taken together, these findings suggest that DMF, by increasing mitochondria, has the potential to lessen the symptoms of muscle diseases, which are caused at least in part by mitochondrial abnormalities," said Cortopassi, who for 25 years has focused on better understanding "orphan" mitochondrial diseases—disorders so rare that no therapies have been developed for them.

In 2011 he established Ixchel Pharma in an effort to identify existing drugs and customize them for treating patients with Friedreich's and other mitochondrial diseases.

Explore further: Scientists find potential treatment for Friedreich's ataxia

Related Stories

Scientists find potential treatment for Friedreich's ataxia

February 16, 2016
Researchers at UT Southwestern Medical Center have identified synthetic RNA and DNA that reverses the protein deficiency causing Friedreich's ataxia, a neurological disease for which there is currently no cure.

What is the cost of rare diseases such as Friedreich's Ataxia?

February 27, 2013
What is the cost of rare diseases such as Friedreich's Ataxia? By analyzing direct and indirect costs of care research in BioMed Central's open access journal Orphanet Journal of Rare Diseases calculated that conservatively ...

Friedreich's ataxia: An effective gene therapy in an animal model

April 6, 2014
The team led by Hélène Puccio, director of research for Inserm at the Institute of Genetics and Molecular and Cellular Biology in close collaboration with Patrick Aubourg's team has demonstrated, in the mice, the efficacy ...

Researchers identify potential treatment for type of muscle and brain degenerative disease

March 21, 2017
UCLA researchers have discovered the molecular basis of, and identified potential treatment for, an incurable disease known as inclusion body myopathy, Paget disease with frontotemporal dementia, or IBMPFD. Using both genetically ...

Recommended for you

Genome analysis with near-complete privacy possible, say researchers

August 17, 2017
It is now possible to scour complete human genomes for the presence of disease-associated genes without revealing any genetic information not directly associated with the inquiry, say Stanford University researchers.

Science Says: DNA test results may not change health habits

August 17, 2017
If you learned your DNA made you more susceptible to getting a disease, wouldn't you work to stay healthy?

Genetic variants found to play key role in human immune system

August 16, 2017
It is widely recognized that people respond differently to infections. This can partially be explained by genetics, shows a new study published today in Nature Communications by an international collaboration of researchers ...

Phenotype varies for presumed pathogenic variants in KCNB1

August 16, 2017
(HealthDay)—De novo KCNB1 missense and loss-of-function variants are associated with neurodevelopmental disorders, with or without seizures, according to a study published online Aug. 14 in JAMA Neurology.

Active non-coding DNA might help pinpoint genetic risk for psychiatric disorders

August 16, 2017
Northwestern Medicine scientists have demonstrated a new method of analyzing non-coding regions of DNA in neurons, which may help to pinpoint which genetic variants are most important to the development of schizophrenia and ...

Evolved masculine and feminine behaviors can be inherited from social environment

August 15, 2017
The different ways men and women behave, passed down from generation to generation, can be inherited from our social environment - not just from genes, experts have suggested.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.